ArticleNature communications2026
Vacuum-induced interfacial compaction for scalable fabrication of high-performance organic solar cells.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Flexible Side-Chain Dispersant Enables Uniform Self-Assembled Monolayers for 18.67% Organic Solar Cells.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Organic solar cells hold great promise for next-generation photovoltaics, yet their practical deployment is impeded by intrinsic morphological and interfacial limitations that compromise device performance and stability. Herein, we introduce a vacuum-induced interfacial compaction strategy that forms smooth, compact, and strongly adhered multilayer films without conventional thermal or solvent annealing, by promoting dense stacking, suppressing interfacial voids, and improving overall interfacial integrity. Consequently, corresponding devices achieve power conversion efficiencies of 20.51% for rigid and 19.13% for flexible devices, together with a high yield. Notably, device with an active area of 1.0 cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.